Zerga, M. (2025). Bispecific antibodies in the treatment of relapsed/refractory diffuse large B cell lymphoma. Role of epcoritamab. Journal of Hematology, 29(1), 11–21. https://doi.org/10.48057/hematologa.v29i1.639